Kai-Hua, Edward Chow

Chow Kai-Hua, Edward

Appointment(s)
  • Assistant Professor, Department of Pharmacology
Administrative Appointment(s)
  • Principal Investigator, Cancer Science Institute of Singapore, National University of Singapore
Academic Qualifications
  • PhD, University of California, Los Angeles, USA
  • BA, University of California, Berkeley, USA
Research Interest(s)
  • Cancer Stem Cells
  • Nanomedicine
  • Therapeutic Combination Optimisation
  • Epigenetics
  • Hematologic Malignancies
Recent Publications
  • 1. Rashid, M. B. M. A., Toh, T. B., Hooi, L., Silva, A., Zhang, Y., Tan, P. F., . . . Chow, E. K. -H. (2018). Optimizing drug combinations against multiple myeloma using a quadratic phenotypic optimization platform (QPOP).. Sci Transl Med, 10(453). doi:10.1126/scitranslmed.aan0941.
  • 2. Fong, E. L. S., Toh, T. B., Lin, Q. X. X., Liu, Z., Hooi, L., Rashid, M. B. M. A., . . . Yu, H. (2018). Datasets describing the growth and molecular features of hepatocellular carcinoma patient-derived xenograft cells grown in a three-dimensional macroporous hydrogel. Data in Brief, 18, 594-606. doi:10.1016/j.dib.2018.03.045.
  • 3. Gu, M., Wang, X., Toh, T. B., & Chow, E. K. -H. (2018). Applications of stimuli-responsive nanoscale drug delivery systems in translational research. DRUG DISCOVERY TODAY, 23(5), 1043-1052. doi:10.1016/j.drudis.2017.11.009.
  • 4. Zhao, Y., Shuen, T. W. H., Toh, T. B., Chan, X. Y., Liu, M., Tan, S. Y., . . . Chen, Q. (2018). Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy. Gut. doi:10.1136/gutjnl-2017-315201.
  • 5. Fong, E. L. S., Toh, T. B., Lin, X., Liu, Z., Hooi, L., Rashid, M. B. M. A., . . . Yu, H. (2018). Generation of matched patient-derived xenograft in vitro-in vivo models using 3D macroporous hydrogels for the study of liver cancer. BIOMATERIALS, 159, 229-240. doi:10.1016/j.biomaterials.2017.12.026.